Cancer Immunotherapy

Original Presentation Date:
04/15/2016

Free (Non-CE / CE Eligible)
Free for Premium Membership subscribers

Veterinary Clinics of North America: Small Animal Practice, Vol 40(3), May 2010, pp 507-518. Author: Philip J. Bergman. Member fee: $7.95 - Login to purchase
×

Course Registration

Completed

Need Help ? Contact Us

You might also like

Recent Advances in Cancer Immunotherapy

01/09/2023

Immunotherapy has tremendous potential for treatment of cancer in dogs. Clinical trials of antibody...

Read More

Cancer Attributable to Infection? What we know about the genus Bartonella and its role in the development of hemangiosarcoma in dogs

06/08/2022

The word cancer is a fairly non-specific term and includes a variety of diseases stemming from abnor...

Read More

Cancer Attributable to Infection? What we know about Bartonella and hemangiosarcoma in dogs

06/06/2022

Presented by Edward Breitschwerdt, DVM, DACVIM Access an evaluation / Earn CE credit by viewing t...

Read More

Cancer Diagnosis in Dogs & Cats - The Impact of Second Opinion Histopathology

03/31/2022

Seeking a second opinion is commonplace in human medicine. Recently published data from an evaluatio...

Read More

An Integrative Approach to the Care of Cancer Patients - An Evidenced Based Approach to the Use of Herbs and Dietary Supplements

02/19/2021

The focus of this presentation is on the rational use of complementary therapies to alleviate physic...

Read More

Vitamin D - Levels in Healthy Dogs and Cancer Patients

11/23/2020

Part II on the discussion of vitamin D, its association with inflammation and chronic disease in dog...

Read More